Literature DB >> 21605631

Rat strain differences in restraint stress-induced brain cytokines.

V M Porterfield1, Z R Zimomra, E A Caldwell, R M Camp, K M Gabella, J D Johnson.   

Abstract

Induction of brain cytokines during times of stress has potent effects on altering behavior, mood, and cognitive functioning. Currently, it is unknown why exposure to some stressors such as tailshock and footshock elevate brain cytokines, while exposure to swim, predator odor, and restraint stress do not. Recent data indicate that brain noradrenergic signaling mediates brain cytokine production suggests magnitude of norepinephrine release during stress may be critical in initiating brain cytokine production. The aim of the current study was to investigate stress-induced brain cytokines between rat strains that differ in their magnitude of stress responsiveness as measured by brain norepinephrine and HPA responses. Sprague-Dawley and Fischer rats were placed in a restraint bag for 1 h or 2 h and sacrificed immediately following stressor termination. Exposure to restraint significantly elevated hypothalamic interleukin (IL)-1β and IL-1 receptor type (R) 2 mRNA after 1 h and IL-1β protein after 2 h in the high stress responsive Fischer rats, but not in Sprague-Dawley rats. IL-6, IL-1R1, Il-1 receptor antagonist (RA), and cyclooxygenase (Cox)-2 mRNA were not altered and neither there was expression of any cytokines in the hippocampus or circulating cytokines in either strain. Administration of desipramine (a norepinephrine reuptake inhibitor) to Sprague-Dawley rats was sufficient either alone or in combination with stress to increase IL-1β mRNA in the hypothalamus and desipramine combined with stress was sufficient to increase IL-1R2 mRNA in the hypothalamus. These data support our hypothesis that there is a critical threshold of brain norepinephrine necessary to stimulate brain cytokines, which may help to explain why severe stressors are more commonly reported to induce brain cytokines. These data also suggest an organisms' susceptibility to stress-induced brain cytokine production, depends on responsiveness and regulation of noradrenergic neurons.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605631      PMCID: PMC3117931          DOI: 10.1016/j.neuroscience.2011.05.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Beta-adrenoceptor mediated surgery-induced production of pro-inflammatory cytokines in rat microglia cells.

Authors:  Jun Wang; Jing Li; Xiao Sheng; Hui Zhao; Xiao-Ding Cao; Yan-Qing Wang; Gen-Cheng Wu
Journal:  J Neuroimmunol       Date:  2010-05-10       Impact factor: 3.478

2.  Neither acute nor chronic exposure to a naturalistic (predator) stressor influences the interleukin-1beta system, tumor necrosis factor-alpha, transforming growth factor-beta1, and neuropeptide mRNAs in specific brain regions.

Authors:  C R Plata-Salamán; S E Ilyin; N P Turrin; D Gayle; M C Flynn; T Bedard; Z Merali; H Anisman
Journal:  Brain Res Bull       Date:  2000-01-15       Impact factor: 4.077

3.  Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress.

Authors:  Peter Blandino; Christopher J Barnum; Lyvia G Solomon; Yaniv Larish; Benjamin S Lankow; Terrence Deak
Journal:  Brain Behav Immun       Date:  2009-05-21       Impact factor: 7.217

4.  Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1beta protein response to acute stress.

Authors:  K T Nguyen; T Deak; M J Will; M K Hansen; B N Hunsaker; M Fleshner; L R Watkins; S F Maier
Journal:  Brain Res       Date:  2000-03-24       Impact factor: 3.252

5.  Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study.

Authors:  Tomohiro Kobayashi; Etsuko Hayashi; Midori Shimamura; Mine Kinoshita; Niall P Murphy
Journal:  Psychopharmacology (Berl)       Date:  2008-02-15       Impact factor: 4.530

6.  Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice.

Authors:  J B Buchanan; N L Sparkman; J Chen; R W Johnson
Journal:  Psychoneuroendocrinology       Date:  2008-04-14       Impact factor: 4.905

7.  Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression.

Authors:  I Goshen; T Kreisel; O Ben-Menachem-Zidon; T Licht; J Weidenfeld; T Ben-Hur; R Yirmiya
Journal:  Mol Psychiatry       Date:  2007-08-14       Impact factor: 15.992

8.  Role of central beta-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge.

Authors:  John D Johnson; Valerie Cortez; Sarah L Kennedy; Teresa E Foley; Hugo Hanson; Monika Fleshner
Journal:  Brain Behav Immun       Date:  2008-05-12       Impact factor: 7.217

Review 9.  Interleukin-1 (IL-1): a central regulator of stress responses.

Authors:  Inbal Goshen; Raz Yirmiya
Journal:  Front Neuroendocrinol       Date:  2008-11-05       Impact factor: 8.606

10.  Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.

Authors:  Rodolfo Bongiovanni; Erica Newbould; George E Jaskiw
Journal:  Brain Res       Date:  2007-11-04       Impact factor: 3.252

View more
  18 in total

1.  A cross-sectional comparison of ethanol-related cytokine expression in the hippocampus of young and aged Fischer 344 rats.

Authors:  Anny Gano; Tamara L Doremus-Fitzwater; Terrence Deak
Journal:  Neurobiol Aging       Date:  2017-03-17       Impact factor: 4.673

Review 2.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

3.  Sex differences in the regulation of brain IL-1β in response to chronic stress.

Authors:  David F Barnard; Kristin M Gabella; Adam C Kulp; Austin D Parker; Patrick B Dugan; John D Johnson
Journal:  Psychoneuroendocrinology       Date:  2019-01-25       Impact factor: 4.905

4.  The effects of acute stress on Pavlovian-instrumental transfer in rats.

Authors:  Steffi M Pielock; Stephanie Braun; Wolfgang Hauber
Journal:  Cogn Affect Behav Neurosci       Date:  2013-03       Impact factor: 3.282

5.  Sympathetic nervous system contributes to enhanced corticosterone levels following chronic stress.

Authors:  Steven A Lowrance; Amy Ionadi; Erin McKay; Xavier Douglas; John D Johnson
Journal:  Psychoneuroendocrinology       Date:  2016-02-26       Impact factor: 4.905

Review 6.  Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF.

Authors:  George R Breese; Darin J Knapp
Journal:  Alcohol       Date:  2016-02-24       Impact factor: 2.405

7.  Evidence for TNFα action on excitatory and inhibitory neurotransmission in the central amygdala: a brain site influenced by stress.

Authors:  Zhen Ming; Hugh E Criswell; George R Breese
Journal:  Brain Behav Immun       Date:  2013-06-11       Impact factor: 7.217

8.  The cytokine mRNA increase induced by withdrawal from chronic ethanol in the sterile environment of brain is mediated by CRF and HMGB1 release.

Authors:  Buddy A Whitman; Darin J Knapp; David F Werner; Fulton T Crews; George R Breese
Journal:  Alcohol Clin Exp Res       Date:  2013-07-29       Impact factor: 3.455

Review 9.  Novel aspects of glucocorticoid actions.

Authors:  E T Uchoa; G Aguilera; J P Herman; J L Fiedler; T Deak; M B C de Sousa
Journal:  J Neuroendocrinol       Date:  2014-09       Impact factor: 3.627

10.  Sensitized corticosterone responses do not mediate the enhanced fear memories in chronically stressed rats.

Authors:  Adam C Kulp; Brett M Lowden; Sachi Chaudhari; Cassidy A Ridley; James C Krzoska; David F Barnard; Devanshi M Mehta; John D Johnson
Journal:  Behav Brain Res       Date:  2020-01-15       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.